Clinical Trial Update: Patient Reported Symptom Control With THC or CBD Use

View source ↗

Summary

This clinical trial update discusses patient-reported symptom control with tetrahydrocannabinol (THC) or cannabidiol (CBD) in cancer patients, including hematol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• Cannabidiol (cannabidiol)
• Tetrahydrocannabinol (delta-9-tetrahydrocannabinol)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cancer-Associated Pain, Hematopoietic and Lymphoid Cell Neoplasm | Status: ACTIVE_NOT_RECRUITING